Tortugas Neuroscience

Tortugas Neuroscience is a preclinical-stage biotechnology company focused on developing novel small molecule therapeutics for central nervous system (CNS) disorders. The company's primary approach involves the activation of the potassium-chloride cotransporter 2 (KCC2), a protein essential for maintaining chloride homeostasis in neurons. By restoring KCC2 function, Tortugas aims to treat conditions characterized by neuronal over-excitation, such as epilepsy and neuropathic pain. The leadership team includes veterans from Sage Therapeutics, bringing significant expertise in neuroscience drug discovery. The company is backed by leading life science investors including ARCH Venture Partners and GV.